Today's News | Note: News feeds may no longer be available for the articles on this page.

InterMune's New Hep C Drug Falls Short 7:28 AM 1/12/2009
TheStreet.com - USA
InterMune has moved forward with development of the new hepatitis C drug ITMN-191 hoping it will be better than a similar drug from Vertex Pharmaceuticals. ...

Repros' endometriosis pain drug shows positive results 7:22 AM 1/12/2009
Reuters - USA
Repros Therapeutics Inc said its experimental drug Proellex significantly reduced pain in a mid-stage trial in women suffering from endometriosis. ...

Glaxo signs early drug discovery deal with UK firm 5:04 AM 1/12/2009
Reuters - USA
GlaxoSmithKline signed a three-year deal with drug discovery company Biotica Technology for its early-stage work in inflammatory disease. ...

Antibiotic maker now ailing 5:42 AM 1/11/2009
Indianapolis Star - United States
The US FDA rejected Targanta's first product oritavancin last month asking them to conduct a new clinical trial that could cost $40 million. Targanta said it would lay off 75 percent of its staff. ...

Osteoporosis drug Fosamax linked to serious diseases 5:42 PM 1/9/2009
Los Angeles Times - CA,USA
Two recent reports have linked the osteoporosis drug Fosamax (alendronate) to 23 cases of esophageal cancer including eight deaths. ...

Anesiva gets OK to expand use of pain drug Zingo 10:17 AM 1/9/2009
Reuters - USA
Anesiva Inc received approval from the US FDA to expand the use of Zingo to treat the pain associated with blood draws. Share price soared. ...

A Wolfe in Regulator's Clothing: Drug Industry Critic Joins the FDA 7:33 AM 1/9/2009
Wall Street Journal - USA
Pro-industry critics call him the "general secretary of junk science" because of his call for a "black box" warning about blindness and erectile-dysfunction drugs. That organ and blindness just seem to go hand-in-hand. ...

FDA Backs Cholesterol Drug Vytorin 5:37 PM 1/8/2009
Washington Post - United States
The US FDA said there was no significant difference in carotid artery thickness between patients taking Vytorin and those taking Zocor. Levels of LDL cholesterol decreased by 56 percent in the Vytorin group compared to 39 percent for Zocor. ...

Orexigen obesity drug leads to 9.3 pct weight loss 3:33 PM 1/8/2009
Reuters - USA
Orexigen Therapeutics Inc found that obese patients treated with experimental drug Contrave lost about 4% percent more weight compared with placebo. ...

Eli Lilly faces FDA delay on schizophrenia drug 8:33 AM 1/8/2009
Forbes - NY,USA
Eli Lilly said that the US FDA is withholding approval on the long-acting version of schizophrenia treatment olanzapine. ...

The Value Of New Drugs Is Dropping 7:37 AM 1/8/2009
Forbes - NY,USA
The US FDA approved 24 brand new medicines in 2008. That's the most in three years, but sales were down. ...

Facet Biotech to cut 80 jobs, narrow focus on oncology 4:19 PM 1/7/2009
Reuters - USA
Facet Biotech Corp was spun-off from PDL BioPharma Inc at the end of 2008. Facet to cut about 80 jobs to reduce expenses and focus on oncology drug candidates. ...

Wyeth Is in Talks to Acquire Vaccine Maker Crucell 2:44 PM 1/7/2009
Wall Street Journal - USA
Wyeth is in talks to purchase vaccine maker Crucell NV. Crucell could be valued at more than $1.3 billion. ...

US FDA staff backs CSL, GTC blood clot drugs 12:05 PM 1/7/2009
Reuters - USA
FDA staff said GTC Biotherapeutics Inc's anti-clotting drug Atryn and CSL Ltd's clot disorder treatment Riastap appear safe and effective. ...

Wyeth CEO Cautious About Economy's Effect On 2009 Results 9:48 AM 1/7/2009
CNNMoney.com - USA
Wyeth's top executive expressed caution about prospects for 2009 because of the economic recession. ...

<- Day Earlier | Today's News